Observational Study - ILM Peeling

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2010 by University Hospital Tuebingen.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University Hospital Tuebingen
ClinicalTrials.gov Identifier:
NCT01083056
First received: March 8, 2010
Last updated: March 9, 2010
Last verified: March 2010
  Purpose

This observational study investigates the effects of epimacular membrane peeling on the structure and function of the retina.


Condition
Epimacular Gliosis
Macular Hole

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Observational Study On Retinal Structure And Function Before And After Epimacular Membrane Peeling

Further study details as provided by University Hospital Tuebingen:

Estimated Enrollment: 50
Study Start Date: March 2010
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
Epimacular Gliosis Without Macular Hole
Epimacular Gliosis With Macular Hole

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Inpatients at the University Eye Hospital Tuebingen

Criteria

Inclusion Criteria:

  • Clinical diagnosis of Epimacular Gliosis
  • Must be scheduled for ILM-peeling independently of study
  • Must be older then 18 years of age

Exclusion Criteria:

  • Visual acuity > 0,4 logMAR (< 20/50 EDTRS)
  • Other ophthalmological disorder affecting visual acuity and/or visual field and/or retinal structure
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01083056

Contacts
Contact: M. Dominik Fischer, MD +49 7071 29 ext 83721 Dominik.Fischer@med.uni-tuebingen.de
Contact: Gabriel Willmann, MD +49 7071 29 ext 83721 Gabriel.Willmann@med.uni-tuebingen.de

Locations
Germany
Centre for Ophthalmology, University Hospital Tuebingen Recruiting
Tuebingen, BW, Germany, 72076
Contact: M. Dominik Fischer, MD    +49 7071 29 ext 83721    Dominik.Fischer@med.uni-tuebingen.de   
Principal Investigator: Florian Gekeler, MD         
Sub-Investigator: M. Dominik Fischer, MD         
Sub-Investigator: Gabriel Willmann, MD         
Sub-Investigator: Andreas Schatz, MD         
Sponsors and Collaborators
University Hospital Tuebingen
Investigators
Principal Investigator: Florian Gekeler, MD Centre for Ophthalmology, University Hospital Tuebingen
  More Information

No publications provided

Responsible Party: PD Dr. med. Florian Gekeler, Centre for Ophthalmology, University Eye Hospital & Institute for Ophthalmic Research
ClinicalTrials.gov Identifier: NCT01083056     History of Changes
Other Study ID Numbers: ILM Peeling
Study First Received: March 8, 2010
Last Updated: March 9, 2010
Health Authority: Germany: Ministry of Health

Keywords provided by University Hospital Tuebingen:
retina
gliosis
macula
membrane
ILM

Additional relevant MeSH terms:
Gliosis
Retinal Perforations
Pathologic Processes
Retinal Diseases
Eye Diseases

ClinicalTrials.gov processed this record on July 26, 2014